Skip to main navigation
Skip to search
Skip to main content
OSU Center for Health Sciences Research Profiles Home
Help & Contact
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Angiogenesis modulation by nicotine and nicotinic ligands
Shaker A. Mousa,
Hugor Arias
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Angiogenesis modulation by nicotine and nicotinic ligands'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Disease
100%
Malignant Neoplasm
100%
Nicotinic Receptor
100%
Diabetes Mellitus
100%
Cellular Processes
100%
Cholinergic Receptor Blocking Agent
100%
Tumor Growth
100%
Cholinergic Receptor Stimulating Agent
100%
Methyllycaconitine
100%
Mecamylamine
100%
Mitogen Activated Protein Kinase
100%
Bungarotoxin
100%
Integrin
100%
Wound Healing
100%
Ischemia
100%
Atherosclerosis
100%
Tissue Repair
100%
Cigarette Smoke
100%
Keyphrases
Acetylcholine Receptor (AChR)
100%
Nicotine
100%
Nicotinic Ligands
100%
Angiogenesis
100%
Endothelial Cells
30%
Non-neuronal
30%
Selective Antagonist
10%
Nicotinic Acetylcholine Receptor (nAChR)
10%
Cell Proliferation
10%
Cellular Processes
10%
Pharmacological Properties
10%
Physiological Processes
10%
Integrin
10%
Non-selective
10%
Pharmacological Data
10%
Intracellular Signaling
10%
Mitogen-activated Protein Kinase
10%
Cigarette Smoking
10%
Ischemia
10%
Diabetic
10%
Methyllycaconitine
10%
Heteromer
10%
Cholinergic Agonists
10%
Mecamylamine
10%
Wound Healing
10%
Enhancing Tumor
10%
Cell Survival
10%
Cholinergic Antagonists
10%
Homomeric
10%
Angiogenic
10%
α-bungarotoxin
10%
Cell Development
10%
Endothelial Cell Proliferation
10%
Tumor Progression
10%
ERK Pathway
10%
Anticancer Therapy
10%
Revascularization
10%
Antiangiogenic Activity
10%
Blood Vessel Formation
10%
Angiogenesis Pathways
10%
Tissue Healing
10%